Print   Email

Investor Relations

Rockwell Medical is a public company trading on the NASDAQ Exchange under the symbol RMTI.


Recent Releases

Apr 28, 2016
Rockwell Medical Announces Triferic® Presentation "Overcoming Functional Iron Deficiency in Your Hemodialysis Patients" at the National Kidney Foundation (NKF) Spring Clinical Meeting in Boston, MA April 29, 2016

Apr 26, 2016
U.S. FDA Approves Rockwell's Triferic® Powder Packet for Treating Anemia in Hemodialysis Patients

View all releases »

Stock Information
NASDAQ : RMTI
$8.95  
Delayed at least 20min., by eSignal.
Stock price graph
3 Mo.   6 Mo.   1 Yr.